ANDA 88877, held by Lannett. Benztropine Mesylate.
As of Nov 22, 2026, ANDA 88877 (Benztropine Mesylate), held by Lannett, was first approved by FDA on Apr 11, 1985, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 11, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Benztropine Mesylate0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet;oral | Benztropine Mesylate | Discontinued |
| May 28, 2002 | Supplement 25Labeling | Approved | None posted |
| Nov 30, 2000 | Supplement 24Manufacturing | Approved | None posted |
| Jul 26, 2000 | Supplement 23Manufacturing | Approved | None posted |
| Jul 2, 1998 | Supplement 20Manufacturing | Approved | None posted |
| Jul 2, 1998 | Supplement 17Manufacturing | Approved | None posted |
| Feb 27, 1998 | Supplement 22Labeling | Approved | None posted |
| Nov 26, 1997 | Supplement 19Manufacturing | Approved | None posted |
| Nov 26, 1997 | Supplement 18Manufacturing | Approved | None posted |
| May 27, 1994 | Supplement 13Manufacturing | Approved | None posted |
| Sep 27, 1993 | Supplement 16Labeling | Approved | None posted |
| Aug 28, 1991 | Supplement 15Labeling | Approved | None posted |
| Jun 12, 1991 | Supplement 12Labeling | Approved | None posted |
| Dec 29, 1988 | Supplement 11Manufacturing | Approved | None posted |
| Dec 29, 1988 | Supplement 10Manufacturing | Approved | None posted |
| Dec 29, 1988 | Supplement 9Manufacturing | Approved | None posted |
| Apr 29, 1986 | Supplement 5Manufacturing | Approved | None posted |
| Apr 29, 1986 | Supplement 4Manufacturing | Approved | None posted |
| Dec 19, 1985 | Supplement 3Manufacturing | Approved | None posted |
| Dec 19, 1985 | Supplement 2Manufacturing | Approved | None posted |
| Apr 11, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters